During Friday’s Current trade, Shares of Arista Netoperates Inc (NYSE:ANET), lost -6.49% to $65.35.
Arista Netoperates unveiled at VMworld 2015, HP OneView support for its award-winning programmable network portfolio. The joint solution automates and integrates HP’s Converged Systems of servers and storage with Arista by seamlessly provisioning virtual infrastructure, allowing IT teams to dramatically improve operations while reducing costs and manual errors that cause downtime.
The solution utilizes the programmability of Arista EOS (Extensible Operating System) and its CloudVision suite to leverage HP OneView’s application programming interfaces (APIs) to automatically provision virtual local area network (VLAN) interfaces between HP Virtual Connect and Arista’s programmable platforms with no administrative intervention. In large scale cloud data center deployments, this translates into noteworthysavings in time and operational expense such as deployment, updating, migrating and troubleshooting. Time spent on these processes is reduced from hours or days to minutes.
Arista Netoperates, Inc. provides cloud networking solutions. The company offers extensible operating systems, a set of network applications, and Ethernet switches. It serves a range of industries, counting Internet companies, service providers, financial services organizations, government agencies, media and entertainment companies, and others. Arista Netoperates, Inc. markets its products through direct sales force and channel partners, such as distributors, value-added resellers, systems integrators, and original equipment manufacturer partners.
Shares of Spark Therapeutics Inc (NASDAQ:ONCE), inclined 0.27% to $44.15, during its current trading session.
Spark Therapeutics, Inc. (ONCE) declared database lock for the Phase 3 clinical trial of its lead program, SPK-RPE65, for the treatment of RPE65-mediated inherited retinal dystrophies. The datasets have been transferred to the company’s independent external statistical consultants, who have initiated the analysis of the data. Spark anticipates that it will provide top-line results in October.
In addition, Spark stated the following modifications to its final SAP:
- Designation of pupillary light reflex as an exploratory endpoint and the analysis of the mobility test change score for an assigned first eye as a secondary endpoint, resulting in three secondary endpoints — full-field light sensitivity threshold testing, the first eye mobility test change score, and visual acuity — which will be tested hierarchically in that order; and
- Adjustment to the intent-to-treat (ITT) population (n=31), which will be the main efficacy analysis population, in addition to addition of a modified ITT population (n=29) and clarification of a per-protocol population (n=28), both of which will be used as sensitivity efficacy analysis groups.
Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. The company is developing SPK-RPE65, which is in Phase III clinical trial for the treatment of inherited retinal dystrophies, a group of rare blinding conditions caused by non-sex linked, or autosomal recessive, mutations in the RPE65 gene. It is also developing SPK-CHM for the treatment of choroideremia; and preclinical programs in development for the treatment of hemophilia A and neurodegenerative diseases, in addition to a pipeline of product candidates targeting rare blinding conditions.
Alaska Air Group, Inc. (NYSE:ALK), during its Thursday’s current trading session decreased -0.15% to $81.20.
Alaska Airlines inaugurates new service between Los Angeles (LAX) and Baltimore, offering introductory one-way fares of $134.* Customers must purchase their tickets by Sept. 18 and travel by Nov. 18, 2015 to take advantage of the introductory fare.
Alaska Air Group, Inc., through its auxiliaries, provides passengers and cargo air transportation services primarily in the United States. The company operates through Alaska Mainline and Alaska Regional segments. It serves about 100 cities in Alaska, the Lower 48, Hawaii, Canada, and Mexico.
Finally, Lincoln National Corporation (NYSE:LNC), decreased -0.78%, to $49.35.
Lincoln Financial Group (LNC) declared that Karen Fowler-Williams, senior vice president of Employee Relations, has received Profiles in Diversity Journal’s 2015 Women Worth Watching® award in recognition of her passion, potential and positive influence inside and outside the workplace. The women highlighted in this year’s issue represent corporations, government agencies and nonprofits from across North America and Europe.
Fowler-Williams joined Lincoln Financial Group in 1989, and she has been an integral part of the company’s Human Resources leadership team, which is responsible for HR governance enterprise-wide. In her role, she oversees HR policy development, employee relations, Equal Employment Opportunity (EEO) compliance and risk administration, threat assessment, recognition, tuition reimbursement, and other employee programs.
Lincoln National Corporation, through its auxiliaries, engages in multiple insurance and retirement businesses in the United States. It operates through Annuities, Retirement Plan Services, Life Insurance, and Group Protection segments. The company sells a range of wealth protection, accumulation, and retirement income products and solutions.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
